Corporate Round - Innate Pharma - Oct 24, 2018 Funding Round Profile - Cointime

Bitcoin $88,748.48 -4.51%
Ethereum $3,138.95 -5.02%
BNB $632.60 -0.42%
Optimism $1.59 -5.84%
Arbitrum $0.60 -6.31%
Solana $214.89 -2.45%
Polygon $0.36 -7.69%
Cosmos $4.99 -6.43%
Avalanche $32.39 -6.31%

Bitcoin $88,748.48 -4.51%
Ethereum $3,138.95 -5.02%
BNB $632.60 -0.42%
Optimism $1.59 -5.84%
Arbitrum $0.60 -6.31%
Solana $214.89 -2.45%
Polygon $0.36 -7.69%
Cosmos $4.99 -6.43%
Avalanche $32.39 -6.31%

Innate Pharma

company

Funding Round

Corporate Round

Money Raised

€ 62.60M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
AstraZeneca	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 1, 2004	Series C	€ 15M	Novo Nordisk,Akka Venture,etc.	Detail
Jan 1, 2002	Series B	€ 20M	Akka Venture	Detail